药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cinolazepam
Cortivazol
The risk or severity of adverse effects can be increased when Cortivazol is combined with Hydrocortisone butyrate.
Cinolazepam
Acteoside
The risk or severity of adverse effects can be increased when Acteoside is combined with Hydrocortisone butyrate.
Cinolazepam
Deoxyspergualin
The risk or severity of adverse effects can be increased when Deoxyspergualin is combined with Hydrocortisone butyrate.
Cinolazepam
Doxifluridine
The risk or severity of adverse effects can be increased when Doxifluridine is combined with Hydrocortisone butyrate.
Cinolazepam
Trofosfamide
The risk or severity of adverse effects can be increased when Trofosfamide is combined with Hydrocortisone butyrate.
Cinolazepam
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Cepeginterferon alfa-2B is combined with Hydrocortisone butyrate.
Cinolazepam
Gusperimus
The risk or severity of adverse effects can be increased when Gusperimus is combined with Hydrocortisone butyrate.
Cinolazepam
Mizoribine
The risk or severity of adverse effects can be increased when Mizoribine is combined with Hydrocortisone butyrate.
Cinolazepam
Ocrelizumab
The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Hydrocortisone butyrate.
Cinolazepam
Deflazacort
The risk or severity of adverse effects can be increased when Deflazacort is combined with Hydrocortisone butyrate.
Cinolazepam
Guselkumab
The risk or severity of adverse effects can be increased when Guselkumab is combined with Hydrocortisone butyrate.
Cinolazepam
Sirukumab
The risk or severity of adverse effects can be increased when Sirukumab is combined with Hydrocortisone butyrate.
Cinolazepam
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Hydrocortisone butyrate.
Cinolazepam
Sarilumab
The risk or severity of adverse effects can be increased when Sarilumab is combined with Hydrocortisone butyrate.
Cinolazepam
Peficitinib
The risk or severity of adverse effects can be increased when Peficitinib is combined with Hydrocortisone butyrate.
Cinolazepam
Voclosporin
The risk or severity of adverse effects can be increased when Voclosporin is combined with Hydrocortisone butyrate.
Cinolazepam
Pirarubicin
The risk or severity of adverse effects can be increased when Pirarubicin is combined with Hydrocortisone butyrate.
Cinolazepam
Ravulizumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Hydrocortisone butyrate.
Cinolazepam
Ixekizumab
The risk or severity of adverse effects can be increased when Ixekizumab is combined with Hydrocortisone butyrate.
Cinolazepam
Melengestrol
The risk or severity of adverse effects can be increased when Melengestrol is combined with Hydrocortisone butyrate.